Increased expression of IDO1 correlates with a decreased level of infiltrating CD3+ T-cells, CD8+ T-cells, CD57+ NK-cells, B-cells, and increased level of Foxp3+ Treg in various types of malignant tumors [107]. Here, IDO1 is linked to cancer.